Amisulpride Injection Now Available in the US for Postoperative Nausea and Vomiting
August 25th 2020Amisuplride injection (Barhemsys; Acacia) is the first and only antiemetic to be approved for the rescue treatment of PONV in patients who have failed prior prophylaxis with an agent of a different class.
FDA Clears First Prescription Game-Based Treatment Device for Children With ADHD
June 17th 2020EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.
FDA OKs Atezolizumab Plus Bevacizumab for Frontline Treatment of Advanced Liver Cancer
June 1st 2020Officials with the FDA approved atezolizumab (Tecentriq, Genentech) in combination with bevacizumab (Avastin) for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.